Exact Mass: 314.1266508
Exact Mass Matches: 314.1266508
Found 165 metabolites which its exact mass value is equals to given mass value 314.1266508,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(R)-3-(METHYLAMINO)-1-PHENYLPROPANOLHYDROCHLORIDE
3-[4-(3-Trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one
C15H17F3N2O2 (314.12420579999997)
Methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate
Molinate
Cyclopropyl-methoxycarbonyl metomidate
D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018755 - GABA Agonists
N-Bicyclo[2.2.1]hept-5-en-2-yl-N-(3-cyano-4,6-dimethyl-2-oxo-1,2-dihydropyridin-1-yl)thiourea
C16H18N4OS (314.12012580000004)
1,1-(2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-diyl)diethanone
1alpha,2alpha,3alpha,4alpha,10alpha-Pentahydroxyguaia-11(13)ene-12,6alpha-olide
beta-D-1C-(1S*,2R*,3R*,4S*,1,2,3,4,5-pentahydroxypentyl)glucopyranoside|diospyrodin
1-(4-hydroxyphenyl)-2-propanol 4-O-beta-D-glucopyranoside
(2S,3R,3aR,4R,4S,5R,7R,8aR)-octahydro-3,4-dihydroxy-3-(hydroxymethyl)-5-methyl-3H-spiro[4,7-methanofuro[3,2-c]oxepine-2,2-pyran]-6(4H)-one|glochicoccin A
2-O-beta-D-galactofuranosyl-D-arabinitol|O2-beta-D-Galactofuranosyl-D-arabit|O2-beta-D-galactofuranosyl-D-arabitol
1alpha-hydroxypseudoanisatin|1??-Hydroxypseudoanisatin
1-(4-methoxy-2,5-dimethylphenyl)-beta-D-glucopyranose|dunnianoside H
1,13,14-trihydroxy-3,4-anhydrofloridanolide|dunnianolide B
(11)7,14-ortholactone of 14-hydroxy-3-oxofloridanolide
SPA-9C (TENTATIVE)
C15H22O5S (314.11878820000004)
TENTATIVELY IDENTIFIED SPECTRUM ONLY!!!!!!!!!; Extracted (without noise removal) from ZUE_N: mz313_11_rt10_56_HCD60_SPA-9C; CONFIDENCE Tentative identification: isomers possible (Level 3); Good match to 6phiC9SPC, LIT00035
8phiC9SPC
C15H22O5S (314.11878820000004)
Literature spectrum; CONFIDENCE Identification confirmed with Reference Standard (Level 1); Digitised from figure: approximate intensities
6phiC9SPC
C15H22O5S (314.11878820000004)
Literature spectrum; CONFIDENCE Identification confirmed with Reference Standard (Level 1); Digitised from figure: approximate intensities
trimethylene bis(4-aminobenzoate)
CONFIDENCE standard compound; INTERNAL_ID 291; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7854; ORIGINAL_PRECURSOR_SCAN_NO 7850 CONFIDENCE standard compound; INTERNAL_ID 291; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7867; ORIGINAL_PRECURSOR_SCAN_NO 7864 CONFIDENCE standard compound; INTERNAL_ID 291; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7905; ORIGINAL_PRECURSOR_SCAN_NO 7903 CONFIDENCE standard compound; INTERNAL_ID 291; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7898; ORIGINAL_PRECURSOR_SCAN_NO 7895 CONFIDENCE standard compound; INTERNAL_ID 291; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7906; ORIGINAL_PRECURSOR_SCAN_NO 7902
2-[4-(2-Pyridinyl)phenyl]-1H-benzimidazole-4-carboxamide
2-[[2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetyl]amino]acetic acid
4-[(4-METHYL-BENZYLAMINO)-METHYL]-3-NITRO-BENZOICACIDMETHYLESTER
(3-((2-Morpholinoethyl)carbamoyl)phenyl)boronic acid hydrochloride
C13H20BClN2O4 (314.12045800000004)
1-(4-methoxyphenyl)-2,3,4,9-tetrahydro-1H-beta-carboline hydrochloride
4-(1-Phenyl-1H-benzimidazol-2-yl)phenylboronic acid
2-(4-((TERT-BUTOXYCARBONYL)AMINO)PHENYL)NICOTINIC ACID
Methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate
D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D003292 - Convulsants
[4-(2-Phenyl-1H-benzimidazol-1-yl)phenyl]-boronic acid
(3-(4-(2-Hydroxyethyl)piperazine-1-carbonyl)phenyl)boronic acid hydrochloride
C13H20BClN2O4 (314.12045800000004)
1-Propanol,2-[(tetrahydro-2H-pyran-2-yl)oxy]-,4-methylbenzenesulfonate,(2S)-
C15H22O5S (314.11878820000004)
2-[4-(4-chlorophenyl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
6,7-dimethoxy-1-(4-nitrophenyl)-1,2,3,4-tetrahydroisoquinoline
3-(1-phenyl-1H-benzo[d]iMidazol-2-yl)phenylboronic acid
Molidustat
C471 - Enzyme Inhibitor Molidustat (BAY 85-3934) is a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase (HIF-PH) with mean IC50 values of 480 nM for PHD1, 280 nM for PHD2, and 450 nM for PHD3.
(E)-3-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-2-propenenitrile
(R,R)-(+)-1-(1-Naphthyl)-2-(2-naphthyl)-1,2-ethanediol
4-Chloro-2-fluoro-5-propoxyphenylboronic acid, pinacol ester
2-(4-Chloro-2-fluoro-5-isopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
3-(4-((TERT-BUTOXYCARBONYL)AMINO)PHENYL)PICOLINIC ACID
4-[4-(2-Hydroxyethyl)-1-piperazinylcarbonyl]benzeneboronic acid
C13H20BClN2O4 (314.12045800000004)
METHYL 6-(4-METHOXYPHENYLAMINO)-5-OXO-1,2,3,5-TETRAHYDROINDOLIZINE-8-CARBOXYLIATE
1,2-Hydrazinedicarboxylicacid, 1-methyl-, 1,2-bis(phenylmethyl) ester
1H-Imidazole-5-carboxylic acid, 1-((1R)-1-phenylethyl)-, 1-(methoxycarbonyl)cyclopropyl ester
D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018755 - GABA Agonists
N-cyclopentyl-2-[[6-(2-pyridinyl)-3-pyridazinyl]thio]acetamide
C16H18N4OS (314.12012580000004)
N-[2-(Diethylamino)ethyl]-2-hydroxy-5-(methylsulfonyl)benzamide (Desmethyltiapride)
C14H22N2O4S (314.13002120000004)
2-Hydroxy-5-{[(1E)-2-phenylethylidene]amino}-L-tyrosine
8-Methyl-8-(4-sulfophenyl)octanoic acid
C15H22O5S (314.11878820000004)
1-[[Oxo(3-pyridinyl)methyl]amino]-3-(4-propan-2-ylphenyl)thiourea
C16H18N4OS (314.12012580000004)
N-[(E)-[4-(4-Fluoroanilino)-4-oxobutan-2-ylidene]amino]pyridine-2-carboxamide
C16H15FN4O2 (314.11789819999996)
1-(2,5-Dimethoxyphenyl)sulfonyl-4-ethylpiperazine
C14H22N2O4S (314.13002120000004)
N-[2-[(phenylmethyl)amino]-1,3-benzodioxol-2-yl]carbamic acid ethyl ester
3-(2-fluorophenyl)-2-(4-fluorophenyl)-5,6,7,7a-tetrahydro-3H-pyrrolo[1,2-c]imidazol-1-one
C18H16F2N2O (314.12306299999995)
1-[[2-(3-Methylanilino)-1-oxoethyl]amino]-3-phenylthiourea
C16H18N4OS (314.12012580000004)
N-[2-(1-naphthalenyloxy)-1-oxoethyl]-2-oxolanecarbohydrazide
(7-Methoxy-4,5-dihydrobenzo[g][1,2]benzoxazol-3-yl)-(4-morpholinyl)methanone
1,4-dideoxy-1-({2,6-dioxo-5-[(E)-(2-oxopropylidene)amino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-erythro-pentitol
C12H18N4O6 (314.12262880000003)
6-(butan-2-ylthio)-1-(4-methylphenyl)-2H-pyrazolo[3,4-d]pyrimidin-4-one
C16H18N4OS (314.12012580000004)
3-{(3E)-4-hydroxy-6-oxo-3-[(2-phenylethyl)imino]cyclohexa-1,4-dien-1-yl}-L-alanine
A non-proteinogenic L-alpha-amino acid obtained by formal condensation of the 3-oxo group of L-topaquinone with the amino group of 2-phenylethylamine.
1,2-dideoxy-1-({2,6-dioxo-5-[(E)-(2-oxopropylidene)amino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-erythro-pentitol
C12H18N4O6 (314.12262880000003)
[(1S,2aS,8bS)-2-[(2-chlorophenyl)methyl]-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol
[(1R,2aR,8bR)-2-[(2-chlorophenyl)methyl]-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol
[(1S,2aR,8bR)-2-[(2-chlorophenyl)methyl]-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol
[(1R,2aS,8bS)-2-[(2-chlorophenyl)methyl]-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol
2-(3,4-dichlorophenyl)-N-methyl-N-[(1-methylpiperidin-2-yl)methyl]ethanamine
C16H24Cl2N2 (314.13164439999997)
[(3R,4R)-1-(5-aminopentylamino)-4,5-dihydroxy-2-oxopentan-3-yl] dihydrogen phosphate
2-hydroxy-5-[(1E)-(2-phenylethylidene)amino]-L-tyrosine
An imine that is L-tyrosine bearing an additional hydroxy substituent at position 2 as well as a (2-phenylethylidene)amino substituent at position 5.
2-[(1r,2s,4s,5r,6r)-5-[(1s)-1-carboxy-1-hydroxyethyl]-2-ethenyl-4,6-dihydroxy-2-methylcyclohexyl]prop-2-enoic acid
9h-pyrido[3,4-b]indole-3-carboxylic acid; methyl isobutyrate
3a-chloro-2-(2-hydroxypropan-2-yl)-6-(3-methylbuta-1,3-dien-1-ylidene)-hexahydro-1-benzofuran-4,5-diol
4-{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy}pentane-1,2,3,5-tetrol
(2s,3s,4r)-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentane-1,2,3,5-tetrol
(1s,2r,6s,7r,8s,10r,13r)-2,7,8-trihydroxy-6-(hydroxymethyl)-7,13-dimethyl-4,9-dioxatetracyclo[6.5.1.0¹,¹⁰.0⁶,¹⁰]tetradecan-3-one
(2s,3r,4s,5s,6r)-2-{2-[(1s)-1-hydroxyethyl]-3-methylphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(3as,6r,6ar,7r,8s,9r,9as,9bs)-6,6a,7,8,9-pentahydroxy-6,9-dimethyl-3-methylidene-hexahydro-3ah-azuleno[4,5-b]furan-2-one
4,12,13-trihydroxy-9-(hydroxymethyl)-6,10-dimethyl-3,14-dioxatetracyclo[6.5.1.0¹,¹⁰.0⁴,⁹]tetradecan-5-one
1-(4-hydroxyphenyl)-2-propanol
{"Ingredient_id": "HBIN001504","Ingredient_name": "1-(4-hydroxyphenyl)-2-propanol","Alias": "NA","Ingredient_formula": "C15H22O7","Ingredient_Smile": "NA","Ingredient_weight": "314.335","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9667","PubChem_id": "NA","DrugBank_id": "NA"}
1α-hydroxypseudoanisatin
{"Ingredient_id": "HBIN002310","Ingredient_name": "1\u03b1-hydroxypseudoanisatin","Alias": "NA","Ingredient_formula": "C15H22O7","Ingredient_Smile": "CC1(CC(C2(C13CC(=O)C(C2(COC(=O)C3)C)(C)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10667","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6,6a,7,8,9-pentahydroxy-6,9-dimethyl-3-methylidene-hexahydro-3ah-azuleno[4,5-b]furan-2-one
(1'r,3s,4's,7'r,8's)-6'-hydroxy-1-methoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-5'-en-2-one
(1r,2s,5s,6r,10r,13r)-2,5,10,13-tetrahydroxy-2,6,13-trimethyl-8-oxatricyclo[4.4.3.0¹,⁵]tridecane-9,12-dione
(2s,5as,7s,9as)-7-bromo-2-ethyl-3,6,6,9a-tetramethyl-2,5,5a,7,8,9-hexahydro-1-benzoxepine
C16H27BrO (314.12451519999996)
(2s,3r,4s,5s,6r)-2-{2-[(1r)-1-hydroxyethyl]-3-methylphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
methyl n-[4-({4-[(methoxycarbonyl)amino]phenyl}methyl)phenyl]carbamate
(1s,2r,5s,6s)-2,5,6-trihydroxy-4-(3-hydroxy-3-methylbut-1-en-1-yl)cyclohex-3-en-1-yl 2-(hydroxymethyl)prop-2-enoate
3-[2-hydroxy-4-methoxy-3-(1,2,3-trihydroxy-3-methylbutyl)phenyl]propanoic acid
(3as,6r,6ar,7s,8r,9r,9as,9br)-6,6a,7,8,9-pentahydroxy-6,9-dimethyl-3-methylidene-hexahydro-3ah-azuleno[4,5-b]furan-2-one
1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]pentane-1,2,3,4,5-pentol
(3as,6r,6ar,7s,8r,9s,9as,9br)-6,6a,7,8,9-pentahydroxy-6,9-dimethyl-3-methylidene-hexahydro-3ah-azuleno[4,5-b]furan-2-one
(1r,2s,4r,9r,11s,12r,13r)-2,11,12-trihydroxy-13-(hydroxymethyl)-12,13-dimethyl-6,14-dioxatetracyclo[9.2.1.0¹,⁹.0⁴,⁹]tetradecan-7-one
[6-methyl-7-(methylamino)-5,8-dioxoisoquinolin-1-yl]methyl (2z)-2-methylbut-2-enoate
2-[(1s)-1-aminoethyl]-n-[2-(1h-indol-3-yl)ethyl]-1,3-thiazole-4-carboximidic acid
C16H18N4OS (314.12012580000004)